Abstract
Our objectives were to (1) identify the risk factors involved in patients with peptic ulcer disease and determine if they predict bleeding in these patients, (2) determine the association between these risk factors, and (3) analyze the cost effectiveness of various tests for Helicobacter pylori (H. pylori). Two-hundred and thirty patients were included in our study between January 2004 and June 2005 (128 bleeding peptic ulcer disease patients constituted the cases, 102 nonbleeding ulcer patients constituted the controls). H. pylori infection was assessed by urease test and biopsy from gastric antrum. There was no statistically significant difference between these groups regarding sex, age, or location of ulcer. Nonsteroidal anti-inflammatory drug (NSAID) use was higher in the case group (P < 0.001), and the rate of H. pylori infection was lower in these patients (P < 0.05). There was no interaction between NSAID use and H. pylori infection in predicting bleeding ulcer risk (P = 0.08). Sensitivity and specificity for urease test in detecting H. pylori was 75% and 99.7%, respectively. So a positive urease test does not need confirmation with biopsy, which is cost effective.
Similar content being viewed by others
References
Mellemkjaer L, Blot WJ, Sorensen HT (2002) Upper gastrointestinal bleeding among users of NSAIDs: a population-based cohort study in Denmark. Br J Clin Pharmacol 53:173–181. doi:10.1046/j.0306-5251.2001.01220.x
Hernandez-Diaz S, Rodriguez LA (2000) Association between nonsteroidal anti-inflammatory drugs and upper gastrointestinal tract bleeding/perforation: an overview of epidemiology studies published in the 1990s. Arch Intern Med 24:2093–2099. doi:10.1001/archinte.160.14.2093
Sorenson HT, Mellemkjaer L, Blot WJ et al (2000) Risk of upper gastrointestinal bleeding associated with the use of low dose aspirin. Am J Gastroenterol 95:2218–2224
Kelly JP, Kaufman DW, Jurgelon JM, Sheehan J, Koff RS, Shapiro S (1996) Risk of aspirin associated major upper gastrointestinal bleeding with enteric-coated or buffered product. Lancet 348:1413–1416. doi:10.1016/S0140-6736(96)01254-8
Garcia Rodriguez LA, Cattaruzzi C, Troncon MG, Agostinis L (1998) Risk of hospitalization for upper gastrointestinal tract bleeding associated with Ketorolac, other NSAIDs calcium antagonists, and other antihypertensive drugs. Arch Intern Med 158:33–39. doi:10.1001/archinte.158.1.33
Garcia Rodriguez LA, Jick H (1994) Risk of upper gastrointestinal bleeding and perforation associated with individual non-steroidal anti-inflammatory drugs. Lancet 343:769–772. doi:10.1016/S0140-6736(94)91843-0
Slattery J, Warlow CP, Shorrock CJ, Langman MJ (1995) Risks of gastrointestinal bleeding during secondary prevention of vascular events with aspirin-analysis of gastrointestinal bleeding during the UK-TIA trial. Gut 37:509–511. doi:10.1136/gut.37.4.509
Okan A, Tankurt E, Aslan BU, Akpinar H (2003) Relationship between non-steroidal anti-inflammatory drug use and Helicobacter pylori in bleeding or uncomplicated peptic ulcers: a case–control study. J Gastroenterol Hepatol 18:18–25. doi:10.1046/j.1440-1746.02889.x
Lanas A, Fuentes J, Benito R et al (2002) Helicobacter pylori infection increases the risk of upper gastrointestinal bleeding in patients taking low dose aspirin. Aliment Pharmacol Ther 16:779–786. doi:10.1046/j.1365-2036.2002.01230.x
Huang JQ, Sridhar S, Hunt RH (2002) Role of Helicobacter pylori infection and non-steroidal anti-inflammatory drugs in peptic ulcer disease: a Meta analysis. Lancet 359:14–22. doi:10.1016/S0140-6736(02)07273-2
Stack WA, Antherton JC, Hawkey GM et al (2002) Interactions between Helicobacter pylori and other risk factors for peptic ulcer bleeding. Aliment Pharmacol Ther 16:497–506. doi:10.1046/j.1365-2036.2002.01197.x
Laine L (2002) Review article: the effect of Helicobacter pylori infection on nonsteroidal anti-inflammatory drug-induced upper gastrointestinal tract injury. Aliment Parmacol Ther 16:34–39. doi:10.1046/j.1365-2036.2002.0160s1034.x
Ramsoekh D, Van Leerdam ME, Raums EAJ, Tytgat GNJ (2005) Outcome of peptic ulcer bleeding, Nonsteroidal Anti-inflammatory drug use, and Helicobacter pylori infection. Clin Gastroenterol Hepatol 3:859–864. doi:10.1016/S1542-3565(05)00402-7
Papatheodorodis GV, Sougioultzis S et al (2006) Effects of H. pylori and nonsteroidal anti-inflammatory drugs on peptic ulcer disease: a systematic review. Clin Gastroenterol Hepatol 4:130–142. doi:10.1016/j.cgh.2005.10.006
Arkkila PET, Seppala K, Kosunen TU, Haapiainen R, Kivilaakso E, Sipponen P (2003) Eradication of Helicobacter pylori improves the healing rate and reduces the relapse rate of non-bleeding ulcers in patients with bleeding peptic ulcer. Am J Gastroenterol. 98:2149–2156. doi:10.1111/j.1572-0241.2003.07682.x
Gisbert JP, Khorammi , Carballo F et al (2004) Meta-analysis: Helicobacter pylori eradication therapy vs. anti-secretory non-eradication therapy for the prevention of recurrent bleeding from peptic ulcer. Aliment Pharmacol Ther 19:617–629. doi:10.1111/j.1365-2036.2004.01898.x
Zapata-Colindres JC, Zepeda-Gomez S, Montano-Loza A et al (2006) The association of H. pylori and non steroidal anti-inflammatory drugs in peptic ulcer disease. Can J Gastroenterol 20:277–280
Xia HH, Wong BC, Wong KW (2001) Clinical and endoscopic characteristics of non-H. pylori, non-NSAID duodenal ulcers: a long term prospective study. Aliment Pharmacol Ther 15:1875–1882. doi:10.1046/j.1365-2036.2001.01115.x
Laine L, Hopkins RJ, Giardi LS (1998) Has the impact of H. pylori therapy on ulcer recurrence in the United States been over stated? A meta-analysis of rigorously designed trails. Am J Gastroenterol 93:1409–1415
Schilling D, Demel A, Adamek HE et al (2003) A negative rapid urease is unreliable for exclusion of Helicobacter pylori infection during acute phase of ulcer bleeding. A prospective case control study. Dig Liver Dis 35:217–221. doi:10.1016/S1590-8658(03)00058-6
Archimandritis A, Tzivras M et al (2000) Rapid urease test is less sensitive than histology in diagnosing Helicobacter pylori infection in patients with non-variceal upper gastrointestinal bleeding. J Gastroenterol Hepatol 15:369–373. doi:10.1046/j.1440-1746.2000.02171.x
Lee JM, Breslin NP, Fallon C et al (2000) Rapid urease tests lack sensitivity in Helicobacter pylori diagnosis when peptic ulcer disease presents with bleeding. Am J Gastroenterol 95:1166–1170. doi:10.1111/j.1572-0241.2000.02004.x
Dickey W, Kenny BD et al (1996) Effect of proton pump inhibitors on the detection of Helicobacter pylori in gastric biopsies. Aliment Pharmacol Ther 10:289–293. doi:10.1111/j.0953-0673.1996.00289.x
Leung WK, Sung JJ, Siu KL, Chan FK et al (1998) False-negative biopsy urease test in bleeding ulcers caused by the buffering effect of blood. Am J Gastroenterol 93:1914–1918. doi:10.1111/j.1572-0241.1998.00457.x
Houghton J, Ramamoorthy R, Pandya H et al (2002) Human plasma is directly bactericidal against H. pylori in vitro, potentially explaining the decreased detection of H. pylori during acute upper GI bleeding. Gastrointest Endosc 55:11–16. doi:10.1067/mge.2002.120391
Ciociola Arthur A, Mcsorley David J, Turner Kathryn (1999) Helicobacter pylori infection rates in duodenal ulcer patients in the United States may be lower than previously estimated. Am J Gastroenterol 94:1834–1840. doi:10.1111/j.1572-0241.1999.01214.x
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Uppalapati, S.S., Boylan, J.D. & Stoltzfus, J. Risk Factors Involved in Patients with Bleeding Peptic Ulcers: A Case–Control Study. Dig Dis Sci 54, 593–598 (2009). https://doi.org/10.1007/s10620-008-0387-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10620-008-0387-7